☆ 4.2 Article

PSMD4 drives progression of hepatocellular carcinoma via Akt/COX2 pathway and p53 inhibition

HUMAN CELL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Physiology

DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS

Giulia Biffi et al.

Summary: Efforts to develop anti-cancer therapies have mainly targeted the epithelial compartment, but recent studies have shown the significant influence of cancer-associated fibroblasts (CAFs) in tumor progression. CAFs not only promote cancer cell proliferation, therapy resistance, and immune exclusion, but may also restrain tumor progression in certain contexts. Research on CAFs has focused on their heterogeneity, plasticity, and functions across different cancer types and states, as well as advancements in therapeutic strategies targeting CAFs currently undergoing preclinical and clinical evaluation.

PHYSIOLOGICAL REVIEWS (2021)

添加到收藏夹

Review Oncology

Mechanisms of Therapeutic Antitumor Monoclonal Antibodies

Li-Chung Tsao et al.

Summary: Monoclonal antibodies are a crucial component of cancer therapy, primarily working by stimulating innate immune effector processes. Different therapeutic mAbs targeting various tumor antigens have shown significant efficacy, with a key role of innate immune-mediated mechanisms observed in mAb therapies against different types of cancer, including HER2(+) solid tumors.

CANCER RESEARCH (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation

Hanchen Xu et al.

Summary: The compound atractylenolide I (ATT-I) has been found to enhance tumor antigen presentation and boost the cytotoxic response of CD8(+) T cells by targeting the function of the immunoproteasome, ultimately improving the tumor response to immunotherapy.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Review Oncology

Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion

Crescenzo D'Alterio et al.

SEMINARS IN CANCER BIOLOGY (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Molecular therapies for HCC: Looking outside the box

Sandrine Faivre et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

The proteasome 19S cap and its ubiquitin receptors provide a versatile recognition platform for substrates

Kirby Martinez-Fonts et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Identification of P-Rex1 in the Regulation of Liver Cancer Cell Proliferation and Migration via HGF/c-Met/Akt Pathway

Wancheng Qiu et al.

ONCOTARGETS AND THERAPY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeted therapy for hepatocellular carcinoma

Ao Huang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Article Genetics & Heredity

Inhibition of PSMD4 blocks the tumorigenesis of hepatocellular carcinoma

Mei-Juan Cai et al.

GENE (2019)

添加到收藏夹

Review Medicine, General & Internal

Hepatocellular Carcinoma

Augusto Villanueva

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Oncology

Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma

Zhiyuan Jiang et al.

CANCER LETTERS (2019)

添加到收藏夹

Review Cell Biology

Ubiquitylation at the crossroads of development and disease

Michael Rape

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

添加到收藏夹

Article Medicine, General & Internal

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo et al.

LANCET (2018)

添加到收藏夹

Article Medicine, General & Internal

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

G. K. Abou-Alfa et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Proteasome Structure and Assembly

Lauren Budenholzer et al.

JOURNAL OF MOLECULAR BIOLOGY (2017)

添加到收藏夹

Review Oncology

Kinase inhibitors and monoclonal antibodies in oncology: clinical implications

Helen Gharwan et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

添加到收藏夹

Review Oncology

The ubiquitin-proteasome system and its potential application in hepatocellular carcinoma therapy

Yan-Jie Chen et al.

CANCER LETTERS (2016)

添加到收藏夹

Review Oncology

Targeting arachidonic acid pathway by natural products for cancer prevention and therapy

Nagendra Sastry Yarla et al.

SEMINARS IN CANCER BIOLOGY (2016)

添加到收藏夹

Article Oncology

Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis

Yudi Pawitan et al.

EUROPEAN JOURNAL OF CANCER (2015)

添加到收藏夹

Article Oncology

Inflammation and cancer: advances and new agents

Shanthini M. Crusz et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Cell Biology

VWA domain of S5a restricts the ability to bind ubiquitin and Ubl to the 26S proteasome

Ravit Piterman et al.

MOLECULAR BIOLOGY OF THE CELL (2014)

添加到收藏夹

Review Biochemistry & Molecular Biology

Ubiquitination in disease pathogenesis and treatment

Doris Popovic et al.

NATURE MEDICINE (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a

A. Sparks et al.

ONCOGENE (2014)

添加到收藏夹

Review Pharmacology & Pharmacy

COX-2-derived endocannabinoid metabolites as novel inflammatory mediators

Mireille Alhouayek et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2014)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Ubiquitin receptors and protein quality control

Xuejun Wang et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure of Rpn10 and Its Interactions with Polyubiquitin Chains and the Proteasome Subunit Rpn12

Christiane Riedinger et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

添加到收藏夹

Review Biochemistry & Molecular Biology

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

S. Whittaker et al.

ONCOGENE (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure of the S5a:K48-Linked Diubiquitin Complex and Its Interactions with Rpn13

Naixia Zhang et al.

MOLECULAR CELL (2009)

添加到收藏夹

Review Cell Biology

Ubiquitin-binding domains - from structures to functions

Ivan Dikic et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3β in gastric cancer cells

A Thiel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

添加到收藏夹

Review Oncology

Cyclooxygenase-2 in hepatocellular carcinoma

T Wu

CANCER TREATMENT REVIEWS (2006)

添加到收藏夹

Review Oncology

COX-2: A molecular target for colorectal cancer prevention

JR Brown et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

添加到收藏夹

Review Oncology

Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention

AJ Dannenberg et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

添加到收藏夹

Article Pharmacology & Pharmacy

Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention

KS Chun et al.

BIOCHEMICAL PHARMACOLOGY (2004)

添加到收藏夹

Review Oncology

Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention

G Davies et al.

ANNALS OF ONCOLOGY (2002)

添加到收藏夹

Article Multidisciplinary Sciences

Surfing the p53 network

B Vogelstein et al.

NATURE (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.